News from the healthcare data industry
Effort aligns MD Anderson’s drug development expertise with Exscientia’s AI-driven patient-first precision medicine and drug discovery platforms MD Anderson News Release November 14, 2022 The University of Texas MD Anderson Cancer Center...
Fast and accurate generative AI design of novel antibodies extends Exscientia’s capabilities beyond small molecules Sequencing paired human antibody data to create better AI models for antibody design Automated laboratory...
Findings support deep learning ex vivo drug screening with patient tissue as a promising tool to identify effective, individual treatments in advanced blood cancer over conventional methods Custom deep learning...
April 08, 2022 04:01 PM Eastern Daylight Time OXFORD, England & VIENNA, Austria–(BUSINESS WIRE)–Exscientia plc (Nasdaq: EXAI) today shared details of its participation at the upcoming American Association for Cancer...
Program open at no-cost to any academic researcher interested in submitting a proposal March 10, 2022 08:00 AM Eastern Standard Time OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) and the University of Oxford...
AI-driven discovery platform enables new way to find novel pathways as well as progress towards identifying patients who may better respond to drugs in the clinic Preclinical data highlights the...
“Hotspot mapping” accelerates early-phase drug design CCDC, Exscientia, and Oxford University collaborate on an automated, quantitative method for informing the design of compound selectivity across protein families Cambridge Crystallographic Data...
Exscientia and Sanofi establish strategic research collaboration to develop AI-driven pipeline of precision-engineered medicines Collaborative efforts aim to accelerate drug discovery and improve clinical success Agreement to utilize Exscientia’s AI-based capabilities...
Sensyne Health PLC (AIM:SENS), the clinical artificial intelligence (AI) company, announced two new partnership deals. The first is a one-year agreement with Exscientia “to leverage the deep learning AI capabilities...